299 related articles for article (PubMed ID: 16352400)
1. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity.
Harrison LM; LaHoste GJ
Neuroscience; 2006; 137(2):483-92. PubMed ID: 16352400
[TBL] [Abstract][Full Text] [Related]
2. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
3. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
Harrison MB; Kumar S; Hubbard CA; Trugman JM
Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
Glavan G; Zivin M
Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820
[TBL] [Abstract][Full Text] [Related]
5. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
6. Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum.
Cai G; Wang HY; Friedman E
J Pharmacol Exp Ther; 2002 Sep; 302(3):1105-12. PubMed ID: 12183669
[TBL] [Abstract][Full Text] [Related]
7. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons.
Errico F; Santini E; Migliarini S; Borgkvist A; Centonze D; Nasti V; Carta M; De Chiara V; Prosperetti C; Spano D; Herve D; Pasqualetti M; Di Lauro R; Fisone G; Usiello A
Mol Cell Neurosci; 2008 Feb; 37(2):335-45. PubMed ID: 18035555
[TBL] [Abstract][Full Text] [Related]
8. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
9. Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes).
Harrison LM; Lahoste GJ; Ruskin DN
Brain Res; 2008 Dec; 1245():16-25. PubMed ID: 18929545
[TBL] [Abstract][Full Text] [Related]
10. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors.
Schwendt M; Gold SJ; McGinty JF
J Neurochem; 2006 Mar; 96(6):1606-15. PubMed ID: 16539683
[TBL] [Abstract][Full Text] [Related]
11. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
Aubert I; Ghorayeb I; Normand E; Bloch B
J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
[TBL] [Abstract][Full Text] [Related]
12. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat.
Ojeda V; Fuentealba JA; Galleguillos D; Andrés ME
J Neurosci Res; 2003 Sep; 73(5):686-97. PubMed ID: 12929136
[TBL] [Abstract][Full Text] [Related]
13. Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion.
Xu ZC; Ling G; Sahr RN; Neal-Beliveau BS
Brain Res; 2005 Mar; 1038(2):163-70. PubMed ID: 15757632
[TBL] [Abstract][Full Text] [Related]
14. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
Maple AM; Perna MK; Parlaman JP; Stanwood GD; Brown RW
Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732
[TBL] [Abstract][Full Text] [Related]
15. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
[TBL] [Abstract][Full Text] [Related]
16. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
Enna SJ; Reisman SA; Stanford JA
Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
[TBL] [Abstract][Full Text] [Related]
17. Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons.
Sciamanna G; Napolitano F; Pelosi B; Bonsi P; Vitucci D; Nuzzo T; Punzo D; Ghiglieri V; Ponterio G; Pasqualetti M; Pisani A; Usiello A
Neurobiol Dis; 2015 Jun; 78():146-61. PubMed ID: 25818655
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time.
Taymans JM; Kia HK; Claes R; Cruz C; Leysen J; Langlois X
Eur J Neurosci; 2004 Apr; 19(8):2249-60. PubMed ID: 15090051
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D(2)-class receptor supersensitivity as reflected in Ca2+ current modulation in neostriatal neurons.
Prieto GA; Perez-Burgos A; Fiordelisio T; Salgado H; Galarraga E; Drucker-Colin R; Bargas J
Neuroscience; 2009 Dec; 164(2):345-50. PubMed ID: 19699276
[TBL] [Abstract][Full Text] [Related]
20. Effect of apomorphine on striatal synaptotagmin 7 mRNA levels in reserpinized rats.
Pal R; Zivin M; Milutinovic A; Jernej B; Glavan G
Neurosci Lett; 2007 Sep; 424(3):194-8. PubMed ID: 17719177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
